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ABSTRACT 
 
AN INVESTIGATION OF CHANGES IN DIABETES TRENDS AFTER THE AFFORDABLE 
CARE ACT 
 
By 
BLAIR CHRISTENSEN 
 
4/15/18 
 
 
INTRODUCTION:  Diabetes Mellitus (DM) is one of the fastest growing and most costly 
chronic diseases in the United States. DM is severely underdiagnosed, resulting in increased 
complications, costs, and mortality. Primary goals of the Affordable Care Act (ACA) were to 
increase health insurance coverage and access to care, and to improve chronic disease outcomes. 
However, the effects of the legislation have not been widely studied, particularly the relationship 
between proper diabetes diagnosis and a variety of health related factors. 
AIM: Determine the relationship between DM prevalence and under-diagnosis, to healthcare 
utilization, usual source of care, insurance, type of insurance, and population characteristics have 
changed since the implementation of the ACA.  
METHODS: Data collected between 2005 and 2016 in the National Health and Nutrition 
Examination Survey were used for this work. The Andersen behavioral health model was used as 
a theoretical framework and selection of study variables. Descriptive statistics and advanced 
statistical modeling techniques were applied. Distinct multilevel models were used to model the 
logit of the probability of DM and the logit of the probability of a proper DM diagnosis each as a 
function of study variables with an indicator of pre- or post-ACA included as a fixed effect. 
Marginal models are multilevel models that apply population averaged estimates for parameters. 
Marginal models were specified to account for clustering by time, and generalized estimating 
equations used to estimate model parameters. The quasi-likelihood under the null (QIC) statistic 
was estimated for model comparisons. The SAS Software System was used for data analysis and 
the level of significance set at .05.   
RESULTS:  The sample consisted of 31,225 participants, with half pre-ACA (n=15,612) and 
half post-ACA. Females comprised 51.64% of the study sample with 43.50% White, 25.82% 
Hispanic, and 20.65% Black and a mean (standard deviation) age of 49.3 (17.9) years. About 
11.45% of those in the Pre ACA period had a diagnosis of DM, while 13.5% of those in the Post 
ACA period had a diagnosis of DM. The percentage of uninsured was 23.95% in the Pre ACA 
 
 
ii 
 
period and 20.69% in the Post ACA time period. The prevalence of undiagnosed DM patients 
was 26.7% before the ACA, and 21.3% after. A multilevel model with DM status as the 
dependent outcome showed that sex (females vs males: OR=0.83, 95%CI=0.78,0.89,p =.02), 
USC (yes vs no: OR=1.28, 95%CI=1.03,1.59, p=.03), health insurance (yes vs no: OR=1.21, 
95%CI=1.17,1.26, p =.02), and education level(college graduate vs less than high school: 
OR=0.79, 95%CI=0.64,0.97, p=.05, high school graduate vs less than high school: OR=0.97, 
95%CI=0.93,1.03, p=.05) were significantly associated with presence of DM. Participants were 
more likely to have their DM properly diagnosed after the ACA: in the final multivariable 
multilevel model, only ACA time period had a significant effect on correct DM diagnosis 
(OR=1.51, 95%CI=1.24,1.85, p=.04).  
CONCLUSIONS: Although prevalence of DM has increased in recent years, under-diagnosis is 
less of an issue after the ACA. In the multivariable model comparing DM status (having the 
disease) to selected covariates, sex, health insurance, education, and USC were related to DM 
status. The ACA time period had no significant relationship with DM status in the multivariable 
model. However, in the multivariable model for correctly diagnosed DM, ACA time period was 
the only independent variable that had a significant association with correct DM diagnosis.  
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Introduction 
Diabetes Mellitus (DM) is one of the fastest growing and most impactful chronic diseases 
in the United States and encompasses several different diseases, all characterized by issues in 
proper insulin manufacture and utilization and resulting high blood glucose levels[1] [2]. 
Chronic diseases have fast been replacing infectious diseases as the primary public health issues 
of interest in developed countries. Those afflicted suffer from not only diminished life 
expectancies but also a decrease in quality of life, and a high burden of expenses and time that 
must be devoted to managing the disease. When a healthcare system is ill-equipped to handle the 
regular maintenance and upkeep of the disease, it is reflected in poor self-care, complications, 
and worsened outcomes, not to mention an increased financial burden at both the individual and 
the system-level. 
DM is also severely underdiagnosed. Nearly a quarter of those with DM have not been 
diagnosed by a doctor[1]. An unknown or late-stage DM diagnosis results in a lack of self-care 
and awareness, manifesting in increased complications, costs, and mortality[3]. Someone who 
has DM but has not been formally diagnosed by a doctor is known as a “missed patient”.  
One of the primary goals of the Affordable Care Act (ACA) was to increase the 
prevalence of health insurance and access to care, and to improve chronic disease outcomes. The 
rationale behind this is that broadened insurance coverage in the population and improved ease 
of access should lead to an increase in utilization, which prior research dictates should improve 
healthcare outcomes. Since the legislation is still relatively new and untested, there is no 
definitive answer as to whether DM-related outcomes have improved.  
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The National Health and Nutrition Examination Survey (NHANES) contains information 
on socio-demographic, behavioral, and laboratory values, and is designed to be representative of 
the entire US population[4]. NHANES provides an ideal data source for an adapted Andersen 
model examining health behaviors and DM outcomes as they relate to the ACA. This adapted 
model can be used as a starting point for multivariate analysis and the eventual construction of a 
multilevel model taking the clustering by survey cycle into account. 
This study will address not only how DM outcomes might have changed following the 
implementation of the ACA but also how the relationship between insurance status (type and 
presence or absence of), utilization, and Usual Source of Care(USC) with DM outcomes may 
have changed along with the shift in the regulatory and policy environment. It will also 
determine if there has been a shift in patterns of diagnosis since the passage of the ACA. 
Previous studies (detailed below) have usually examined only one of these factors’ relationship 
to a health outcome, rather than how they might interact to result in an outcome. For DM, disease 
status is also usually only assessed by clinical diagnosis, which becomes problematic in 
underserved populations that do not utilize healthcare services- a diagnosis is not the best 
reflection of actual disease status in these instances. In this study, a HbA1c blood test is used to 
determine if an individual has DM. By employing a multi-level modeling approach to study time 
periods before and after the passage of the ACA, the disregard for the clustering of the data 
found in many prior studies will be remedied. 
Disentangling the relationship between policy, healthcare behaviors, and DM outcomes is 
important for several reasons. Better understanding the impact of healthcare reform on chronic 
disease outcomes could help to improve and shape future legislation.  An idea of the true 
relationship between complicated sets of healthcare behaviors and causes can also guide 
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healthcare recommendations and improve outcomes for diabetics. Understanding these 
relationships for DM could also help to inform decisions about other chronic diseases. 
The questions this study seeks to answer are: 
I. Controlling for demographic characteristics, has the association between 
insurance status and DM changed since the passage of the ACA? 
II. Controlling for demographic characteristics, has the association between 
healthcare utilization and DM changed since the passage of the ACA? 
III. Controlling for demographic characteristics, has the association between having a 
USC and DM changed since the passage of the ACA? 
IV. What demographic characteristics are associated with being a “missed patient” 
and have the associations changed since the passage of the ACA? 
V.   Has the prevalence of “missed patients” changed since the passage of the ACA?  
Literature Review 
Epidemiology of DM  
DM encompasses several different diseases, all characterized by issues in proper insulin 
manufacture and utilization and resulting high blood glucose levels[1]. Type 2 DM is the most 
common form and can be defined as an acquired intolerance to insulin due to dietary and 
lifestyle factors. The prevalence of DM has been increasing and is projected to continue 
increasing[2]. DM has become a public health crisis, with 30.3 million diabetics in the US, 
nearly a quarter of which (23.8%) are estimated to be undiagnosed[5]. The low diagnosis rates 
are thought to be consequence of the fact that many diabetics do not enter the healthcare system 
until they begin suffering from complications from their disease[1]. Type 2 DM is diagnosed 
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using the HbA1c test, with results greater than or equal to 6.5% indicating controlled DM and 
values above 8% indicating uncontrolled DM[6]. The HbA1c is considered the gold standard in 
diagnosing DM[1]. DM patients spent more than twice as much on medical expenditures and 
non-diabetics[7]. Diabetics have a high burden of maintenance costs, which include regular 
doctor visits, medication, education programs, specialized diets, and other assorted items[8]. In 
addition to the maintenance costs associated with DM, the potential of comorbidities and 
complications from mismanagement and the natural progression of the disease also impose a 
massive burden on the public health system[8-10]. Uncontrolled DM can lead to foot ulcers and 
amputations, eye deterioration, kidney disease, cardiovascular disease, mobility issues, high 
cholesterol, and an overall reduction in both quality of life and overall life span[1]. The 
estimated cost from DM in 2012 was $245B, not including the undiagnosed burden and unpaid 
care[7].  
Health Behaviors and Outcomes 
Andersen’s Behavioral Model of Health Utilization was first proposed in the early 1970’s 
as a way to study and predict individual usage of health services. [11] The next update to the 
model included external and environmental factors, along with incorporating user satisfaction 
with services [12]. The current iteration of the model includes four primary spheres of influence, 
all of which connect and create a kind of feedback loop: Environment, Population 
Characteristics, Health Behavior, and Outcomes.[13, 14] This construction allows for the 
examination of the relationship between complicated sets of healthcare behaviors, demographic 
characteristics, policy and healthcare system changes, and outcomes, both quantitative and 
qualitative. The Andersen model is generally accepted as the best framework when analyzing 
complex and nuanced healthcare concepts, like utilization and access to care [15-17]. 
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Environmental factors can include regulatory environment and policy changes in the health care 
system and time could be incorporated as a variable.  Population characteristics are divided into 
three distinct sections: Predisposing (including Demographic and Social attributes), Enabling 
(including Financial and Accessibility factors) and Need. Need-based characteristics are rooted 
more in perception of need than in actual physical need, including perceived health status and 
previous diagnosis of a disease[13]. Using Andersen’s model allows for a better understanding of 
health behavior and utilization and the inclusion of the necessary characteristics and external 
factors to fully describe the relationship. 
Factors Associated with DM-outcomes 
It has been long established that health outcomes and behavior exhibit distinct racial and 
cultural disparities. Minorities, smokers, those of lower Socioeconomic Status(SES) and those 
with less education are more likely to have DM[18]. DM development and outcomes, along with 
management of care, are also associated with socioeconomic factors and behaviors[19]. 
Perception of health status and denial about health problems is a common reason why health 
services might not be fully utilized or chronic disease care left unmanaged[20]. There are racial 
and socioeconomic class differences in DM screening diagnosis accuracy[21]. Increased 
utilization of health services, medication adherence and disease management were shown to be 
associated with the perception of personal health status [22]. An official diagnosis of DM did not 
seem to influence health behaviors or perception of health status[22].  A 2009 study found that a 
significant proportion of Diabetics (around 10%) had no health insurance coverage, usually due 
to high premium costs[23].   
Health Services Utilization is a multifaceted and difficult to quantify concept. It can be 
defined as “the measure of the population’s use of the health care services available to them,” 
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and can be an indicator of “how efficiently a health care system produces health in a 
population”[24]. Utilization is a behavior pattern determined by demographic characteristics, like 
ethnicity, and external environmental factors, like policy, the effect of which can be measured in 
discrete outcomes. Utilization has been associated with increased mortality in high risk 
groups[25], but this association is not causal and, in general, utilization is associated with 
improved preventative care and health behaviors[26]. Insurance coverage increases the 
likelihood of utilizing care[27]. 
Usual Source of Care(USC) is defined as “a particular doctor’s office, clinic, health 
center, or other place one goes to if one is sick or needs advice about health.”[28] The effects of 
having a USC have been a source of debate in the literature for some time now. One theory is 
that a USC is determined by utilization and only indirectly affects doctor visit frequency, while 
the other is that the lack of a USC serves as a barrier to access, directly minimizing the amount 
of doctor visits and utilization[29]. It has been established that not having a USC can limit 
continuous utilization of services. This is particularly important for DM care, which requires 
consistent monitoring and attention[30, 31]. Having a USC also serves as a proxy for access to 
the overall healthcare system and is associated with improved outcomes and preventative 
care[30, 32]. A USC was found to be a better predictor of access to care than whether or not a 
patient was insured[33].  
Insurance coverage alone does not ensure utilization of care[34-38]. A 2012 study found 
that a USC was more important than health insurance coverage in determining utilization and 
outcomes; children with both a USC and insurance had better outcomes than those with only 
insurance. Having only a USC was more beneficial than only having insurance[34]. While 
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insurance does not ensure access, being insured has been found to be associated with a higher 
quality of care and improved access[39].  
Type of insurance has also been shown to effect health outcomes and perceptions. Less 
physicians accept new patients with public insurance than private, and certain physicians do not 
accept any public insurance coverage[40, 41]. Medicaid users report feeling more stigmatized 
and have worse access and health outcomes than those with private insurance [42]. Private health 
insurance coverage has also been found to be correlated with higher incomes and previous health 
status, and public insurance programs tend to decline in per capita resources and quality of care 
over time[43]. 
Having DM is associated with physician quality and type of insurance plan, and DM 
patients with self-stigma issues had worsened outcomes. [44-46] Poor glycemic control and 
outcomes in DM patients were associated with cost and lack of insurance, isolation, and 
difficulty accessing care[47].   A lack of access and lack of insurance were found to be 
associated with a delay or complete failure to have DM diagnosed, known as being a “missed 
patient”. [48] 
Impact of the ACA 
The passage of the Patient Protection and Affordable Care Act (ACA) was supposed to 
provide renewed focus on lowering barriers to access and expanded, affordable insurance 
coverage. While research has been done on the effects of the legislation, many studies are 
contradictory, small, or focused more in the realm of health economics[49-52]. The ACA 
certainly increased insurance coverage, with the lowest ever amounts of uninsured Americans. It 
is estimated that the number of those without coverage was reduced by around 20 million due to 
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the passage of the ACA, and the effects were present in the entire population, regardless of age, 
race, gender, or level of education[53].  Studies conducted after the implementation of the ACA 
have found improved access to care and higher percentages of insured, compared to before the 
legislation was passed[26]. In Medicaid expansion states, DM outcomes were greatly improved 
and hospitalizations were minimized. [54] Diabetic adults without insurance utilize care less and 
have less access to care. The increased access and coverage provided by the ACA has increased 
the utilization of healthcare services among diabetics, possibly leading to better overall health 
conditions and lower incidence of DM complications.[55]  
In those newly insured due to the ACA, having a USC was more common, preventative 
visits, glucose testing and utilization of services increased, and there was a marked improvement 
in self-reported health status[56]. Socioeconomic status is linked to utilization, and health status 
must be considered when analyzing utilization across different socioeconomic classes[57, 58]. In 
the past, major policy initiatives and shifts in the regulatory environment have been shown to 
influence utilization[59]. 
Gaps in the Literature 
There has been no research comparing the relationship between utilization, access, 
insurance and blood glucose level outcomes before and after the implementation of the 
Affordable Care Act.  This study will address not only how DM outcomes might have changed 
following the implementation of the ACA but also how the relationship between insurance status 
(type and presence or absence of), utilization, and access with DM outcomes may have changed 
along with the shift in the regulatory and policy environment. Among studies that have examined 
one of these factors relationship to DM outcomes, none have used a multilevel modeling 
approach or examined a wide array of NHANES data. Failing to take the clustering of the data 
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into account in this way results in biased parameter estimates and ultimately leads to incorrect 
conclusions.  
There has also been little research on missed patients, and nothing assessing their 
prevalence comparing regulatory environment. Studying underdiagnosis is fundamentally 
difficult, because the true disease status must be determined for those without a diagnosis, 
usually through a blood test. This is much more invasive and resource-intensive than simply 
filling out a questionnaire with disease status. Most previous studies have not analyzed DM 
status as a function of a HbA1c test. The problem of under-diagnosis is remedied, as the results 
of this test are not dependent on having been previously diagnosed with the disease. Previous 
studies examining more than one cycle of NHANES have also often neglected to take the 
clustering of data by year into account. 
Methods 
Data source 
The National Health and Nutrition Examination Survey (NHANES) is completed in 
continuous 2-year cycles by the Centers for Disease Control and was created to examine the 
nutritional and health status of all non-institutionalized adults and children in the United States. 
The survey sample contains around 5000 people each year from 15 United States counties and is 
designed to be nationally representative. NHANES oversamples Blacks, Hispanics, and those 
older than 60 years of age, and the examination portion is more extensive in older participants. 
The interview portion gathers information on socioeconomic, dietary, demographic, and health 
questions. This interview is conducted in the participants home, in a variety of different 
languages. There is also an examination portion, where medical, dental, and physical aspects are 
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measured; laboratory tests are also included. This portion of the survey takes place through 
participant visits to mobile clinics that travel with NHANES [1]. One unique aspect of the survey 
is that it collects biological samples along with questionnaire and demographic data. An HbA1c 
is included in the laboratory data, and has been shown as a useful and accurate indicator of DM 
status and previously undiagnosed DM, particularly in a single-visit setting[60]. This provides a 
unique opportunity when studying DM outcomes- the usual under-diagnosis is a negligible factor 
and does not need to be considered. NHANES also includes information on demographics, use of 
health services, insurance coverage and type, and USC (USC). Socio-demographic 
characteristics and general healthcare questions were utilized from the NHANES questionnaires. 
Three two-year cycles (2005-2006, 2007-2008, and 2009-2010) represented the time period 
before the ACA, and three cycles (2011-2012, 2013-2014, and 2015-2016) for after the ACA. 
Study population 
The study population captured by NHANES are United States residents of all ages who 
are not institutionalized, living in nursing homes, living abroad, or in the armed forces.  
Study sample 
To create the sample, the entire United States (including Alaska and Hawaii) is divided 
into 15 groups, and a single county is selected from each group. Then around 20 smaller 
subdivisions are selected from each county. Roughly 30 households are selected from each 
subdivision, and all household members are interviewed. A random algorithm then selects a 
random number of the participants in each household[4]. Only individuals who had participated 
in the relevant questionnaires and had a measurement for the response variable were included in 
the analysis. Individual observations for some questions could still be missing. Only respondents 
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age 20 or above were included in the final dataset. Table 4.1 includes the measurements for the 
study sample by pre- and post-ACA. 
Dependent Variables 
The traditional HbA1c test findings were used to create the dependent variable. The 
continuous measured value represented the percentage of glycated hemoglobin present in the 
blood. For the analysis, the outcome was created by dichotomizing HbA1c test with a cutoff of 
6.5% or above indicating DM[1]. Only those with non-missing values for the outcome variable 
were selected for the sample(n=31225). “Missed Patient” status was determined by creating a 
new variable from only those above the 6.5% cutoff and whether they had previously received a 
DM diagnosis from a doctor. 
Independent Variables 
Utilization and access were operationalized in this study as the amount of doctor visits in 
the last 12 months and whether an individual had a USC, defined as “a routine place to go for 
healthcare or when you are sick”. Frequency of doctor visits was an ordinal variable with the 
categories: 0 visits, 1 visit, 2-3 visits, 4-9 visits, 10-12 visits, and 13 or more visits. General 
health condition was recoded into a three-category variable: Poor/Fair, Average, and 
Good/Excellent. Insurance status and DM diagnosis were binary variables. Insurance type was 
recoded into Private, Medicare, Medicaid/Medigap, Other, and None. Education was recoded 
into a three-category variable, less-than High school, High school graduate, and College graduate 
or above. Income was assessed using the income to poverty level ratio. Race/Ethnicity was 
broken into 4 categories: Hispanic, White, Black, and other.  
Statistical Analysis 
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The SAS Software System was used for all the statistical analyses. The level of 
significance was set at .05. Although NHANES is a complex multistage weighted survey, 
previous studies have shown that the difference in error that comes from discounting them may 
be potentially insignificant and possibly may not greatly alter inferences made [61]. The methods 
for including survey weights in a multilevel modeling scheme are also complex. The SAS 
Software System multilevel modeling procedures to not allow for simultaneously fitting 
multilevel models and accounting for complex sampling weights. Since a primary interest was in 
accounting for the clustering within survey year to apply multilevel models, these were used and 
survey weights not accounted for in analyses presented here. The caveats and possible 
repercussions of this choice are included in the discussion. 
In repeated measures or clustered longitudinal data, the assumption of independence of 
observations necessary for many modeling techniques (Logistic Regression, ANOVA) is 
violated[62]. In this dataset, there are two levels of variables. The first level is individual 
measurements and the second level is the survey year. Ignoring the clustering of observations 
leads to biased estimation and incorrect standard errors. Multilevel modeling techniques account 
for clustering or grouping of data. Marginal models are a semi-parametric method that averages 
the random effects of the second-level variable to provide a population-averaged coefficient, 
rather than individual-level estimates. This approach allows meaningful conclusions to be drawn. 
Marginal models use Generalized Estimating Equations(GEE) to estimate parameters [63]. A 
Marginal Mixed model was constructed for each Bivariate comparison and for the selected 
multivariable model.  
Variables were selected for inclusion in the final model using a combination of a data-
driven and a theory driven approach. A theoretical relationship between the outcome, health 
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behavior, population characteristics and environment was assessed by creating a modified 
Andersen Behavioral model of Healthcare Utilization. This model was used to select variables to 
be tested for inclusion in the model from the NHANES dataset. Eight possible models were 
identified from the constructed behavior model and tested. Quasi likelihood under the 
Independence Model Criterion(QIC) was then used to select the correlation structure and the 
variables for inclusion in the final model[64]. Although GEE is robust to misclassification of the 
correlation structure, testing for correct structure is efficient and desirable. The structures 
compared in this work were Independence, Compound Symmetry, and First-order 
Autoregressive (a steady and equivalent heterogeneity of variance). Type of insurance was 
assessed only with a bivariate model since health insurance status was already considered in the 
model and to avoid multicollinearity issues. Bivariate comparison models are also included for 
all variables, which allows full examination of how associations are affected by the adjustments 
in the final model. 
For the analysis of missed patients, a subset of the data with only DM patients was 
created(n=3394). Descriptive frequencies were tabulated, stratified by missed patient status and 
before or after ACA time-period. Adjusted and crude by-characteristic Odds Ratio point 
estimates and 95% Confidence Intervals were calculated and p-values reported for a final 
multivariable model.  
Results 
Descriptive Statistics for DM 
Table 4.1 includes the descriptive statistics of socio-demographic, health behavior, and 
DM in persons 20 years and older in NHANES 2005-2010 (before time period or Pre ACA) and 
NHANES 2011-2016(after time period or Post ACA). The overall study sample consisted of 
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31,225 participants, with half pre-ACA (n=15,612) and half post-ACA. Females comprised 
51.64% of the study sample with 43.50% White, 25.82% Hispanic, and 20.65% Black and a 
mean (standard deviation) age of 49.3 (17.9) years. About 11.45% of those in the Pre ACA 
period had a diagnosis of DM, while 13.5% of those in the post ACA period had a diagnosis of 
DM. In the Pre and Post ACA periods respectively, 1.91% and 2.56% had missing values for 
DM diagnosis. The percentage of uninsured decreased from 23.95% in the Pre ACA period to 
20.69% in the Post ACA time period. Overall, less than a tenth of a percent had a missing value 
for insurance. In the overall sample, 25.91% had less than a high school education, 51.52% had a 
high school diploma, and 22.48% were college graduates or higher. Only a tenth of a percent 
were missing education level. Levels of Utilization were constant across both time periods. 
Overall, 16.52% had no doctors visits in the last year, 17.59% had 1 doctors visit in the last year, 
27.07% had 2-3 visits, 25.02% had 4-9 visits, 6.44% had 10-12 visits, and 7.27% had 13 or more 
visits. Less than a tenth of a percent of respondents had a missing value for utilization. Pre ACA 
10.53% had DM, while Post ACA 12.16% had DM. Pre ACA, 7.83% had Medicaid or Medigap, 
18.01% had Medicare, 23.96% had no insurance, 38.8% had private insurance, and 11.16% had 
some other form of insurance. In the Pre ACA period, 0.22% had a missing value for insurance 
type. Post ACA, 11.43% had Medicaid or Medigap, 15.22% had Medicare, 20.75% had no 
insurance, 37.80% had private insurance, and 14.3% had some other form of insurance. In the 
post ACA period, 0.55% had missing values for insurance type. USC was constant across the 
time periods, with 84.68% having a USC Pre ACA and 83.72% having a USC Post ACA. There 
were no responses missing for USC. Health condition also remained constant from Pre to Post 
ACA, with 39.37% reporting poor/fair health, 36.41% reporting average health, and 24.22% 
reporting good/excellent health. Overall, less than a tenth of a percent of responses were missing 
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for health condition, with 0.06% missing from Pre ACA and 0.09% missing from Post ACA. The 
distribution across sexes remained constant across the time periods, with slightly more females 
than males (51.64% and 48.36%, respectively). The distribution of ethnicities across the two 
time periods were slightly different, and there were no missing responses for ethnicity. Pre ACA, 
19.32% of respondents were black, 27.13% Hispanic, 48.94% White, and 4.61% Other. Post 
ACA, 21.98% of respondents were Black, 24.52% Hispanic, 38.06% White, and 15.44% Other. 
Pre ACA, 18.27% of respondents were below the poverty line, with 8.46% missing a response, 
while Post ACA 20.62% were, with 9.32% missing a response. The mean age in years Pre ACA 
was 49.50 and 49.13 Post ACA.   
Associations with Diabetes 
Time-period(Pre or Post ACA), age, sex, utilization, USC, health condition, insurance, 
education, ethnicity, and income were selected for inclusion in the final multivariable multilevel 
model (Table 4.2), and an independent correlation structure was chosen, with 
QIC=16773.27(Table 4.3). 
The final multivariable multilevel model of DM status (table 4.4) showed that the time-
period after the ACA was unrelated to DM in both the bivariate (OR=1.77, 
95%CI=0.99,1.4,p=.07) and the adjusted model (OR=1.90, 95%CI=1.1,1.33,p=.09). Those with 
health insurance were significantly more likely to have DM in the unadjusted analysis (OR=1.51, 
95%CI=1.44,1.58,p<.0001). Once adjusting for covariates, those with DM were also 
significantly more likely to have health insurance (OR=1.21, 95%CI=1.17,1.26, p =.02). Those 
with Medicaid/Medigap (OR=2.17, 95%CI=1.86,2.53,p<.0001), Medicare (OR=2.79, 
95%CI=2.64,2.96,p<.0001), and Other (OR=1.5, 95%CI=1.31,1.7,p<.0001) types of insurance 
were more likely to have DM, compared to those with a private insurance plan. Income above 
 
 
16 
 
the poverty level was not related to DM outcomes in the adjusted model (OR=0.97, 
95%CI=0.86,1.1,p=.28) but was found to be significant in a simple bivariate analysis (OR=0.76, 
95%CI=0.65,0.89,p=.0007). Those with a high school education had lower odds of having DM 
(OR=0.60, 95%CI=0.58,0.68,p<.0001), and this result remained significant in the adjusted model 
(OR=0.97, 95%CI=0.93,1.03,p=.05). College graduates consistently had significantly lower odds 
of having DM in both the multivariable (OR=0.79, 95%CI=0.64,0.97,p=.05) and bivariate 
(OR=0.39, 95%CI=0.36,0.42, p<.0001) model. Compared to Whites in a bivariate model, Blacks 
(OR=1.88, 95%CI=1.63,2.16,p<.0001), Hispanics (OR=1.72, 95%CI=1.52,1.97,p<.0001), and 
those of Other ethnicity (OR=1.35, 95%CI=1.18,1.56,p<.0001) had higher odds of having DM. 
Compared to Whites in the multivariable model, Blacks (OR=1.88, 95%CI=1.68,2.12,p=.11), 
Hispanics (OR=1.99, 95%CI=1.75,1.2.26,p=.11), and those of Other ethnicity (OR=1.85, 
95%CI=1.66,2.05,p=.11) did not have significantly higher odds of having DM. 
Compared to no visits, having one doctor visit in the past year was not associated with 
increased odds of having DM in both the bivariate (OR=1.03, 95%CI=0.99,1.07) and the 
multivariable (OR=1.03, 95%CI=0.93,1.14,p=.31) model. In the bivariate model, having DM 
was correlated with increased doctor visits, ranging from 2-3 visits (OR=1.77, 
95%CI=1.55,2.03,p<.0001), 4-9 visits (OR=3.34, 95%CI=3.23,3.44, p<.0001), 10-12 visits 
(OR=3.99, 95%CI=3.83,4.15, p<.0001) and 13 or more visits (OR=3.28, 95%CI=2.93,3.67, 
p<.0001). In the multivariable model, having DM was correlated with increased doctor visits, 
ranging from 2-3 visits (OR=1.40, 95%CI=1.26,1.55, p<.0001), 4-9 visits (OR=2.06, 
95%CI=1.88,2.27, p<.0001), 10-12 visits (OR=2.12, 95%CI=1.96,2.29, p<.0001) and 13 or more 
visits (OR=1.83, 95%CI=1.61,2.08, p<.0001).   Compared to males, females had lower odds of 
having DM in both the bivariate (OR=0.83, 95%CI=0.78,0.89, p<.0001) and multivariable 
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(OR=0.72, 95%CI=0.67,0.76, p=.02) models. Average health condition was associated with 
decreased odds of having DM, compared to those of poor health condition in both the bivariate 
(OR=2.79, 95%CI=2.51,3.11) and multivariable (OR=2.45, 95%CI=2.22,2.71) models. Those 
who considered themselves in good or excellent condition had very low odds of having DM, 
compared to those in poor health condition in both the bivariate (OR=6.52, 95%CI=5.68,7.48) 
and multivariable (OR=4.82, 95%CI=4.26,5.45) models.  
Descriptive Statistics for DM Diagnosis  
Table 4.5 includes descriptive statistics of the study variables by DM diagnosis before 
and after the ACA. The prevalence of undiagnosed DM patients was less (21.32%) than before 
the ACA (26.73%). In the Pre ACA period, 75.91% of diagnosed patients were insured, 
compared to 81.03% in the Post ACA period. Of diagnosed patients in the Pre ACA period, 
43.2% had less than a high education, 45.8% had a high school education, and 10.8% had a 
college education or higher. The distribution of education among properly diagnosed patients 
post ACA changed slightly, with 33.7%, 49.8%, and 16.8%, respectively. Post ACA, utilization 
increased overall, with 96.5% of those with properly diagnosed DM had at least 1 doctors visit, 
compared to 96.2% Pre ACA. 82.3% of Medicaid/Medigap patients were properly diagnosed 
after the ACA, compared to only 80.1% before.75.6% of those on Medicare were properly 
diagnosed before the ACA, compared to 84.8% after the ACA. Before the ACA, 76.6% of those 
with a USC were properly diagnosed, compared to 80.8% Post ACA. Before the ACA, only 
71.5% percent of males had properly diagnosed DM, compared to 80.9% Post ACA. 77.2% of 
Blacks, 78.2% of Hispanics, 84.34% of Whites, and 71.3% of other ethnicity had properly 
diagnosed DM after the ACA, compared to 74.5%, 71.0%, 74.3%, and 73.3% Pre ACA, 
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respectively. Post ACA, 78.0% of those below the poverty line had properly diagnosed DM, 
compared to 73.8% before.  
Associations with undiagnosed DM 
Table 4.6 contains the final multivariable multilevel model of an indicator of properly 
diagnosed DM with selected covariates. Utilization of at least one doctors visit was significantly 
related to proper DM diagnosis in a bivariate model(p<.0001), but this effect became 
insignificant in the multivariable model (for 1 visit, OR=2.19, 95%CI=1.63,2.94, p=.31). In a 
bivariate model, USC was related to proper DM diagnosis(OR=4.6, 95%CI=3.5,6.05, p<.0001), 
but in a multivariable model USC was not associated with correct DM diagnosis(OR=1.64, 
95%CI=1.09,2.48, p =.07). In a bivariate model, insurance was not significantly associated with 
correct DM diagnosis (OR=1.92,95%CI=0.97,1.26, p=.06), and the association remained 
insignificant in a multivariable model (OR=2.76, 95%CI=2.3,3.81, p=.34).  In a bivariate model, 
Medicaid/Medigap (OR=1.52, 95%CI=1.14,2.02), Medicare (OR=1.37, 95%CI=1.17,1.60), No 
Insurance (OR=0.65, 95%CI=0.53,0.79) and other forms of insurance (OR=1.44, 
95%CI=1.25,1.65) were significantly associated with having correctly diagnosed DM, compared 
to those on private insurance(p<.0001). In the multivariable model, no particular type of 
insurance is associated with having correctly diagnosed DM(p=.69). In a bivariate model, 
good/excellent health condition (OR=2.9, 95%CI=2.4,3.5) and average health condition 
(OR=1.6, 95%CI=1.37,1.85) were associated with correct DM diagnosis, compared to those in 
poor health condition(p<.0001). However, in a multivariable model, this relationship did not 
hold, and good/excellent health condition (OR=2.42, 95%CI=1.88,3.11) and average health 
condition (OR=1.38, 95%CI=1.11,1.71) were not found to be associated to correct DM 
diagnosis, compared to poor health condition(p=.06).  
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We failed to find an association between income and missed patient status. There was no 
significant association in a bivariate model (OR=1.02, p=.82) and income was not included in the 
multivariable model. In a bivariate model, education was not found to be associated with 
properly diagnosed DM (OR=1.11, 95%CI=0.97,1.26, p=.06). In a bivariate model, sex was not 
significant (OR=0.96, 0.71,1.17, p=.69). In a bivariate model, Black (OR=0.84, 
95%CI=0.67,1.06), Hispanic (OR=0.79, 95%CI=0.61,1.02), and Other ethnicity (OR=0.68, 
95%CI=0.47,0.97) were significantly related to correctly diagnosed DM, compared to those of 
White ethnicity (p=.05). However, in a multivariable model, no other ethnicity was associated 
with correctly diagnosed DM, when compared to those of White ethnicity (p-value=.41).  
Individuals were more likely to have their DM properly diagnosed after the ACA, as 
opposed to before. In a bivariate model, the period after the ACA was significantly associated 
(OR=1.34, 95%CI=1.10,1.64, p=.003) with proper DM diagnosis. In a multivariable model 
adjusted for Time Period, Utilization, USC, Health Condition, Insurance, Ethnicity, and 
Insurance Type, only time period was related to correctly diagnosed DM. Those in the period 
after the ACA were more likely (OR=1.51, 95%CI=1.24,1.85, p=.04) to have properly diagnosed 
DM, when compared to those in the time period before the ACA was passed. 
Discussion 
Controlling for demographic characteristics, the association between insurance status and 
DM has not changed since the passage of the ACA. Those with insurance were still much more 
likely to have DM. A possible explanation for this finding is that many of the uninsured are 
young or in good health and do not feel pressure to purchase health insurance. DM prevalence 
also increases with age. In this sample, those with insurance are, on average, 11 years older than 
those without. Using only the NHANES dataset, it is not possible to determine the effect of 
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insurance on the development of DM. A longitudinal study that follows individuals over time 
could determine whether those who have insurance are less likely to develop DM in the future.  
There have not been any studies of this type conducted in the period after the ACA.  
The association between healthcare utilization and DM have not changed since the 
passage of the ACA. While a single yearly doctor’s visit was not significantly associated with 
having DM, it did significantly decrease the odds of being a missed patient. While this 
association has not been studied in among those who are undiagnosed with diabetes, a failure to 
receive annual Primary Care visits has been found to be associated with poorer outcomes and 
increased hospitalizations due to DM[65]. Although utilization above 2 visits was associated 
with an increased chance of having DM, this is expected due to more frequent doctor’s visits by 
diabetics. Diabetics, particularly those with a formal diagnosis, tend to have a much higher 
frequency of physician visits than those without DM[66]. Controlling for previous diagnosis 
might be a way to further explore this relationship. Future studies analyzing utilization should 
consider if subjects have a DM diagnosis.  
Having a USC and level of health services utilization do seem to be linked. Those with a 
USC generally had much higher utilization rates. However, it is still unclear if there is a causal 
pathway between USC and utilization. Like previous studies suggested, having a USC was more 
strongly related to having properly diagnosed diabetes than having health insurance [31, 34]. 
This could be due to the fact that many who are insured have high copays and do not visit the 
doctor enough to establish a USC. This would explain the lower diagnosis rates.  
A higher percentage of subjects had some form of health insurance after the ACA, 
compared to before. This implies that the legislation may have actually led to increased 
healthcare coverage, as it was intended to. Those without health insurance were much more 
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likely to be a missed patient, compared to those with any type of health insurance. If the trend of 
expanded healthcare coverage in the population continues, the prevalence of missed patients 
should continue to decrease.   
Those without insurance were less likely to go to the doctor or have a USC. We did not 
find evidence to support some earlier studies. Earlier studies found those that a USC alone 
improved access and outcomes, but the effect on DM diagnosis rates due to a USC was 
negligible [31]. The link between these factors and being a missed patient had not been 
previously studied. Although insurance, USC, and utilization all independently influenced 
missed patient status, none were found to be significant in an adjusted model.  
Before the ACA, those on Medicaid/Medigap were less likely to be missed patients than 
those with private health insurance. After the ACA, there was no perceptible increase in 
likelihood of having DM properly diagnosed. This contradicts the idea and previous evidence 
that Medicaid expansion lead to better care and more healthcare attention paid to vulnerable 
populations[67]. The failure of Medicaid expansion in some states and changes in funding could 
be responsible for this effect[68]. Although the geographical data collected by NHANES is 
restricted, study of the differences in missed patients and DM outcomes between Expansion and 
Non-Expansion states or different state-level policies could be informative. This would allow for 
a more specific assessment of policies.  
While we did not find any significant effects due to income other than in the bivariate 
model for DM, prior studies have found lower income to be associated with a greater probability 
of developing DM[18]. This could be because the binary indicator for income did not contain 
enough information to capture these differences or that there truly is no effect, particularly when 
other characteristics are accounted for.  
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There were significant disparities and differences in outcomes between races. Compared 
to whites, ethnic minorities were more likely to qualify as a missed patient after the passage of 
the ACA. While ethnic minority changes in missed patient status after the ACA has not been 
studied, a 2016 study found that access for minorities had increased overall[69]. There is no 
research concerning Diabetes outcomes for ethnic and racial minorities in the period after the 
ACA.  Future studies should place an increased focus on outcomes for minorities. Poorer 
outcomes for minorities are a common finding in this study, and targeted interventions are 
needed.  
While this sample does not show a significant difference in DM prevalence between the 
two time-periods, other estimates show that the overall prevalence of DM increased after the 
ACA[1]. Chronic diseases have long latent periods, and it is not realistic to expect any noticeable 
decrease or change in DM occurrence over such a short time period. The increased prevalence of 
DM should not be taken as an indicator that the ACA has been ineffective or has somehow 
contributed to DM cases.  
Controlling for all other relevant factors, ACA time-period was the only significant 
effect, meaning that the time After the ACA was the only factor related to a patient receiving a 
correct DM diagnosis. After the passage of the ACA, patients had lower odds of being a missed 
patient than before the ACA, signifying that the ACA may have had a positive effect on 
awareness of DM and willingness of physicians to screen for DM, even if the prevalence is 
increasing. This effect has not been studied before and is an important piece of evidence in 
determining if the ACA has generated a tangible change in DM diagnosis.  
Methodological Limitations 
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While some research exists concerning other biological measures, there have been no 
studies concerning the validity of the HbA1c results from NHANES[70]. Past studies have found 
that certain biological markers, particularly caloric data, measured by NHANES do not have 
good predictive validity[70]. However, since HbA1c is considered the gold standard for a single-
visit diagnosis of diabetes and past studies have found that DM can be accurately diagnosed from 
HbA1c data, it is reasonable to assume those measurements can be used to predict the presence 
or absence of DM. However, the validity of the NHANES HbA1c values are another matter 
entirely. A 2003 study found that data collected by the survey on blood lead levels suffered from 
widespread methodological errors and failed to approximate the actual population distribution 
levels of lead[71]. While there have been changes in the survey methodology since that time, 
there has been no research on how those changes may have led to better validity.  
Generalizing findings from analyses of NHANES biomarker data is common in the 
literature, but needs further study to ensure that it is valid to do so[72].   NHANES also does not 
select participants from nursing homes, the armed forces, prisons, or those living abroad[4]. As 
these groups make up a significant proportion of the population and ignoring them could lead to 
a lack of generalizability. 
There are also possible measurement issues. While HbA1c values should not be subject 
to bias, not all survey participants are tested and there may be significant differences between 
those tested and those who are not. The methods behind which subjects are tested and why are 
not made clear by the survey, and there is no ‘refused to participate’ or ‘not selected to 
participate’ categories in the laboratory data. NHANES does not provide any information or 
documentation on which participants are selected for blood testing. The particular wording of the 
survey questions could also lead to systematic bias, particularly if wording leads the participant 
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to believe that one response is more desirable than the other, and the self-reported nature of the 
diagnosis questions and much of the healthcare behavior data could be subject to widespread 
inaccuracy.  Primary issues in the questionnaire for this study include recall bias and 
unacceptability of a given response. [73] Whether or not a patient has been diagnosed with DM 
is not verified and based only on the response to a single question.  
Statistical Limitations 
Using retrospective data makes it difficult to establish causality. Future studies could use 
propensity scores and matching to determine causality, rather than just an association.  
Prospective studies could also establish causality.  
A limitation of the GEE method is that all missing values must be assumed to be missing 
completely at random(MCAR). Since there was a low frequency of missing data, and the missing 
values seemed to be evenly distributed and unassociated with any single category, the results 
should not have been significantly affected. Survey weights were not accounted for. Although 
some studies have found that discounting survey weights does not have inferential consequences, 
it still would have been preferable to include them.  
Conclusions 
Since the trends in DM are unlikely to change without massive, societal-level changes, 
focusing on strategies to prevent missed patients seems like a realistic policy focus. Identifying 
populations at risk of being missed patients and focusing efforts and programs in their direction 
will lead to earlier diagnosis and less complications and costs from the disease. Utilization, USC, 
and Insurance would be the best focuses for an intervention, as these are factors that can be 
influenced, unlike demographics. Physicians should be aware of factors that predispose a patient 
to having undiagnosed DM (non-white ethnicity, lower level of education, older age, being 
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uninsured, lack of a USC) and take steps to see if undiagnosed DM could be possible. Patients 
should be more regularly screened for DM. Increasing insurance coverage and encouraging 
regular doctor visits could seriously decrease the amount of undiagnosed cases of DM and the 
associated burden of care. 
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Table 4.1:  Descriptive statistics of socio-demographic, health behavior, and DM study 
variables.  
 
PRE ACA 
Count (%) 
POST ACA 
Count (%) 
TOTAL 
Count (%) 
Variable 15612(50.00%) 15613(50.00%) 31225(100%) 
Diagnosis    
      No 13513(20.08%) 13105(83.94%) 26618(85.25%) 
Yes 1801(11.54%) 2109(13.50%) 3910(12.52%) 
Missing 298(1.91%) 399(2.56%) 697(2.23%) 
Insured    
No 3740(23.95%) 3231(20.69%) 6971(22.33%) 
Yes 
Missing 
11861(75.97%) 
11(0.07%) 
12363(79.18%) 
19(0.12%) 
24224(77.59%) 
30(0.09%) 
Education    
Less than High 
School 
4541(29.09%) 3548(22.72%) 8089(25.91%) 
High School Grad 7963(51.01%) 8123(52.03%) 16086(51.52%) 
College Graduate 
Missing 
3086(19.77%) 
22(0.14%) 
3932(25.18%) 
10(0.06%) 
7018(22.48%) 
32(0.10%) 
Utilization    
0 2590(16.58%) 2567(16.44%) 5157(16.52%) 
1 2697(17.28%) 2795(17.90%) 5492(17.59%) 
2-3 
4-9 
10-12 
>13 
Missing 
4075(26.10%) 
3922(25.12%) 
1096(7.02%) 
1220(7.81%) 
12(0.08%) 
4379(28.05%) 
3890(24.92%) 
916(5.87%) 
1050(6.73%) 
16(0.10%) 
8454(27.07%) 
7812(25.02%) 
2012(6.44%) 
2270(7.27%) 
28(0.09%) 
   Diabetes     
No         13968(89.47%) 13714(87.84%) 27682(88.65%) 
         Yes 1644(10.53%) 1899(12.16%) 3543(11.35%) 
Insurance Type    
      Medicaid/Medigap 1223(7.83%) 1784(11.43%) 3007(9.63%) 
     Medicare 2812(18.01%) 2376(15.22%) 5188(16.61%) 
     None 3742(23.96%) 3239(20.75%) 6981(22.36%) 
     Other 
     Private 
     Missing 
1743(11.16%) 
6058(38.80%) 
34(0.22%) 
2232(14.30%) 
5902(37.80%) 
80(0.51%) 
3975(12.73%) 
11960(38.30%) 
114(0.37%) 
Usual Source of Care    
       No 2391(15.32%) 2542(16.28%) 4933(15.80%) 
Yes 
Missing 
13221(84.68%) 
0 
13071(83.72%) 
0 
26292(84.02%) 
0 
Health Condition    
        Poor/Fair 6267(40.14%) 6018(38.54%) 12885(39.37%) 
        Average 
       Good/Excellent 
5521(35.36%) 
3815(24.45%) 
5839(37.40%) 
3742(23.96%) 
11360(36.41%) 
7557(24.22%) 
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*Missing values included those who responded ‘Don’t Know’ or ‘Refuse to Answer’ 
Definitions: ACA- Affordable Care Act, SD- Standard Deviation, DM- Diabetes Mellitus 
        Missing 9(0.06%) 14(0.09%) 23(0.07%) 
Sex    
        Female 8057(51.61%) 8068(51.67%) 16125(51.64%) 
        Male 7555(48.39%) 7545(48.33%) 15100(48.36%) 
       Missing 0 0 0 
Ethnicity    
        Black 3017(19.32%) 3432(21.98%) 6449(20.65%) 
        Hispanic 4235(27.13%) 3828(24.52%) 8063(25.82%) 
        White 
        Other 
        Missing 
7641(48.94%) 
719(4.61%) 
0 
5942(38.06%) 
2411(15.44%) 
0 
13583(43.50%) 
3130(10.02%) 
0 
Income 
 Below Poverty Line 
Above Poverty Line 
Missing 
 
2852(18.27%) 
11439(73.27%) 
1321(8.46%) 
 
3219(20.62%) 
10939(70.06%) 
1455(9.32%) 
 
6071(19.44%) 
22378(71.67%) 
2776(8.89%) 
    
 Mean (SD) Mean (SD) Mean (SD) 
Age 49.5 (18.2) 49.1 (17.7) 49.3 (17.9) 
 
 
32 
 
Table 4.2: Multilevel marginal model regression coefficient estimates (p-values) for DM status with selected covariates (n=31,225)+. 
 
Variable Model 1 Model 2 Model 3 Model 4  Model 5 Model 6 Model 7 Model 8 
Fixed intercept -4.39 (.01) -4.47 (.01) -4.41 (.01) -5.10 (.002) -5.21 (.002) -4.96 (.001) -4.94 (.01) -4.99 (.003) 
Affordable Care Act 
    
    
After v. Before 0.02(.01) 0.22(.01) 0.22(.01) 0.21(.002) 0.22(.002) 0.23(.001) 0.15(.01) 0.17(.003) 
Age 
    
    
(in years) 0.04(<.0001) 0.04(<.0001) 0.04(<.0001) 0.03(<.0001) 0.04(<.0001) 0.04(<.0001) 0.04(<.0001) 0.04(<.0001) 
Sex(p-value) 
    
    
Female v. Male -0.17(<.0001) -0.25(<.0001) -0.25(<.0001) -0.27(<.0001) -0.28(<.0001) -0.29(<.0001) -0.31(<.0001) -0.33(<.0001) 
Utilization(p-value)  
   
    
1 visit v. no visits  -0.08(<.0001) -0.11(<.0001) -0.02(<.0001) 0.01(<.0001) 0.02(<.0001) 0.02(<.0001) 0.03(<.0001) 
2-3 Visits v. no visits  0.26(<.0001) 0.22(<.0001) 0.23(<.0001) 0.26(<.0001) 0.28(<.0001) 0.30(<.0001) 0.34(<.0001) 
4-9 Visits v. no visits  0.74(<.0001) 0.70(<.0001) 0.55(<.0001) 0.60(<.0001) 0.62(<.0001) 0.68(<.0001) 0.72(<.0001) 
10-12 Visits v. no visits  0.92(<.0001) 0.88(<.0001) 0.58(<.0001) 0.63(<.0001) 0.65(<.0001) 0.72(<.0001) 0.75(<.0001) 
>13 Visits v. no visits  0.77(<.0001) 0.73(<.0001) 0.36(<.0001) 0.42(<.0001) 0.45(<.0001) 0.56(<.0001) 0.61(<.0001) 
Usual Source of Care         
       No v Yes   -0.01(.29) -0.20(.01) -0.25(.004) -0.26(.003) -0.25(.004) -0.25(.03) 
Health condition         
       Good/Excellent v. Poor/Fair   1.17(<.0001) 1.60(<.0001) 1.50(<.0001) 1.39(<.0001) 1.42(<.0001) 
      Average v. Poor/Fair    0.94(<.0001) 0.93(<.0001) 0.88(<.0001) 0.81(<.0001) 0.83(<.0001) 
Insurance         
       No v. Yes     0.17(<.0001) 0.13(.001) 0.09(.01) 0.14(<.0001) 
Education          
      High School v. Less than High School     -0.12(<.0001) -0.006(.05) -0.02(.07) 
     College Graduate v. Less than High School     -0.36(<.0001) -0.23(.05) -0.23(.07) 
Ethnicity          
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     Black v Other       0.05(<.0001) 0.07(<.0001) 
     Hispanic v Other       -0.02(<.0001) 0.019(<.0001) 
     White v Other       -0.68(<.0001) -0.61(<.0001) 
Income         
     Above Poverty Line v. Below       -0.03(.62) 
QIC 20416.35 20074.16 20075.70 19036.59 19010.63 18957.36 18690.69 16774.19 
+Based on QIC, model 8 was selected 
Smaller QIC values indicate a better fitting model 
*Definitions: QIC- Quasi-Information Criterion, ACA- Affordable Care Act, CI- Confidence Interval, OR- Odds Ratio, 
DM- Diabetes Mellitus 
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Table 4.3: Model comparisons across correlation structures*. 
Variable 
Independence First-order 
Autoregressive 
Compound 
Symmetry 
Intercept            Estimate(p-value) Estimate(p-value) Estimate(p-value) 
        -4.99(<.0001) -3.04(<.0001) -4.99(<.0001) 
Affordable Care Act    
After v. Before 0.17(.003) 0.23(.05) 0.17(.003) 
Age    
(in years) 0.04(<.0001) 0.02(<.0001) 0.04(<.0001) 
Sex    
Female v. Male -0.33(<.0001) -0.23(<.0001) -0.34(<.0001) 
Utilization    
1 visit v. no visits 0.03(.53) 0.03(.15) 0.03(.54) 
2-3 Visits v. no visits 0.33(<.0001) .21(<.0001) 0.33(<.0001) 
4-9 Visits v. no visits 0.72(<.0001) 0.49(<.0001) 0.72(<.0001) 
10-12 Visits v. no visits 0.75(<.0001) 0.53(<.0001) 0.75(<.0001) 
>13 Visits v. no visits 0.60(<.0001) 0.42(<.0001) 0.60(<.0001) 
Usual Source of Care    
       No v Yes -0.24(.03) -0.14(.002) -0.25(.03) 
Health condition    
      Good/Excellent v. Poor/Fair 1.41(<.0001) 0.93(<.0001) 1.41(<.0001) 
       Average v. Poor/Fair 0.83(<.0001) 0.47(<.0001) 0.83(<.0001) 
Insurance    
       No v. Yes 0.14(<.0001) 0.06(<.0001) 0.14(<.0001) 
Education     
      High School v. Less than High 
School 
-0.02(.38) -0.04(.01) -0.02(.38) 
College Graduate v. Less than High 
School 
-0.23(.03) -0.17(.001) -0.23(.03) 
Ethnicity    
Black v Other 0.07(.31) 0.06(.16) 0.08(.30) 
Hispanic v Other 0.02(.71) 0.004(.89) 0.02(.68) 
White v Other -0.61(<.0001) -0.41(<.0001) -0.61(<.0001) 
Income    
Above Poverty Line v. Below -0.03(.62) -0.03(.50) -0.03(.63) 
QICµ 16773.27 19399.92 16773.28 
*Based on QICµ, an Independent correlation structure was chosen for the final model 
Smaller QIC values indicate a better fitting model 
Definitions: QIC- Quasi-Information Criterion, ACA- Affordable Care Act, USC- Usual Source of Care, DM- 
Diabetes Mellitus 
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Table 4.4: Final multivariable multilevel marginal model for the association between DM status 
with selected covariates (n=31225). 
Variable Bivariate  Multivariable  
 Unadjusted OR(95%CI) p-value Adjusted OR (95%CI) p-value 
ACA  .07  .09 
After 1.77(0.99,1.40)  1.90(1.06,1.33)  
Before Reference  Reference   
Sex  <.0001  .02 
Female 0.83(0.78,0.89)  0.72(0.67,0.76)  
Male Reference  Reference  
Utilization  <.0001  .31 
No Visits Reference  Reference  
1 Visit 1.03(0.99,1.07)  1.03(0.93,1.14)  
2-3 Visits  1.77(1.55,2.03)  1.40(1.26,1.55)  
4-9 Visits 3.34 (3.23,3.44)  2.06(1.88,2.27)  
10-12 Visits 3.99 (3.83,4.15)  2.12(1.96,2.29)  
>13 Visits 3.28(2.93,3.67)  1.83(1.61,2.08)  
Usual Source of Care   <.0001  .03 
       No Reference  Reference  
       Yes 2.37(2.07,2.73)  1.28(1.03,1.59)  
Health condition  <.0001  .05 
      Good/Excellent 6.52(5.68,7.48)  4.82(4.26,5.45)  
       Average 2.79(2.51,3.11)  2.45(2.22,2.71)  
     Poor/Fair Reference  Reference  
Insurance  <.0001  .02 
       No Reference  Reference  
     Yes 1.51(1.44,1.58)  1.21(1.17,1.26)  
Education   <.0001  .05 
      College Graduate 0.39(0.36,0.42)  0.79(0.64,0.97)  
   High School Graduate 0.60(0.58,0.68)  0.97(0.93,1.03)  
    Less than High School  Reference  Reference  
Ethnicity  <.0001  .11 
Black 1.88(1.63,2.16)  1.88(1.68,2.12)  
Hispanic  1.72(1.52,1.97)  1.99(1.75,2.26)  
Other  1.35(1.18,1.56)  1.85(1.66,2.05)  
White Reference  Reference  
Income  .0007  .28 
Above Poverty Line 0.76(0.65,0.89)  0.97(0.86,1.10)  
Below Poverty Line Reference  Reference  
Insurance Type  <.0001   
Medicaid/Medigap  2.17(1.86,2.53)    
Medicare 2.79(2.64,2.96)    
None 1.05(0.96,1.14)    
Other 1.50(1.31,1.70)    
Private Reference    
A Marginal Model with Generalized Estimating Equations was used to account for clustering within year; 
probability of Diabetes is modeled  
ǂWald 𝜒2 test, at α=0.05 
Missing Data: Diagnosis (N=697), Insurance (N=30), Education (N=32), Utilization (N=28), Diabetes (N=0), 
Insurance Type (N=114), USC (N=0), Health Condition (N=23), Sex (N=0), Ethnicity (N=0), Income 
(N=2776), Age (N=0) 
Definitions: ACA- Affordable Care Act, CI- Confidence Interval, OR- Odds Ratio, DM- Diabetes Mellitus  
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Table 4.5: Descriptive statistics of study variables by DM diagnosis before and after the ACA 
(n=3394). 
 
 
PRE 
n= 
ACA 
1579 
POST 
n=  
ACA 
1815 
 Diagnosed Diagnosed 
 Yes No Yes No 
Variable 1157(73.27%) 422(26.73%) 1428(78.68%) 387(21.32%) 
Insured     
No 184(64.79%) 100(35.21%) 183(65.83%) 95(34.17%) 
Yes 973(75.91%) 321(24.81%) 1243(81.03%) 291(18.97%) 
Education     
Less than High School 500(74.18%) 174(25.82%) 481(78.59%) 131(21.41%) 
High School 530(72.11%) 205(27.89%) 704(78.57%) 192(21.43%) 
College Graduate 125(74.50%) 43(25.60%) 240(79.21%) 63(20.79%) 
Utilization     
0 41(31.78%) 88(68.22%) 54(36.00%) 96(64.00%) 
1 60(45.45%) 72(54.55%) 104(61.18%) 66(38.82%) 
2-3 
4-9 
10-12 
>13 
258(73.30%) 
469(80.72%) 
160(82.05%) 
167(88.83%) 
94(26.70%) 
112(19.28%) 
35(17.95%) 
21(11.17%) 
350(81.59%) 
592(85.55%) 
162(87.10%) 
164(88.17%) 
79(14.45%) 
100(12.90%) 
24(12.90%) 
22(11.83%) 
Insurance Type     
     Medicaid/Medigap 151(80.32%) 37(19.68%) 232(82.27%) 50(17.73%) 
     Medicare 384(75.59%) 124(24.41%) 397(84.47%) 73(15.53%) 
     None 184(64.79%) 100(35.21%) 184(65.71%) 96(34.29%) 
     Other 
     Private 
297(70.88%) 
140(80.00%) 
122(29.12%) 
35(20.00%) 
388(77.29%) 
223(81.09%) 
114(22.71%) 
52(18.91%) 
Usual Source of Care     
       No 46(35.94%) 82(64.06%) 72(54.94%) 64(47.06%) 
Yes 1111(76.57%) 340(23.43%) 1356(80.76%) 323(19.24%) 
Health Condition     
        Poor/Fair 153(61.20%) 97(38.80%) 165(63.71%) 94(36.29%) 
        Average 
       Good/Excellent 
366(68.67%) 
637(80.13%) 
167(31.33%) 
158(19.87%) 
513(75.78%) 
749(85.31%) 
164(24.22%) 
129(14.69%) 
Sex     
        Female 574(75.23%) 189(24.77%) 656(76.28%) 204(23.72%) 
        Male 583(71.45%) 233(28.55%) 772(80.84%) 183(19.16%) 
Ethnicity     
        Black 316(74.53%) 108(25.47%) 376(77.21%) 111(22.79%) 
        Hispanic 359(71.09%) 146(29.91%) 437(78.18%) 122(21.82%) 
        Other 55(73.33%) 20(26.67%) 184(71.32%) 74(28.68%) 
        White 427(74.26%) 148(25.74%) 431(84.34%) 80(15.66%) 
Income     
Above Poverty Line 786(72.58%) 297(27.42%) 909(78.84%) 244(21.16%) 
Below Poverty Line 239(73.77%) 85(26.23%) 364(77.94%) 103(22.06%) 
Missing Data: Insurance(n=4), Insurance Type(n=10), Education (N=6), Utilization (N=4), Usual Source 
of Care (N=0), Health Condition (N=2), Sex (N=0), Ethnicity (N=0), Income (N=367) 
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Table 4.6: Final multivariable multilevel marginal model of an indicator of properly diagnosed DM with 
selected covariates (n=3394). 
Variable Bivariate  Multivariable  
 Unadjusted 
OR(95%CI) 
p-valueǂ Adjusted OR (95%CI) p-valueǂ 
ACA  .003  .04 
After 1.34 (1.10,1.64)  1.51(1.24,1.85)  
Before Reference  Reference   
Sex  .69  
 
Female 0.96 (0.71,1.17)  
 
 
Male Reference  
 
 
Utilization  <.0001  .31 
No Visits Reference  Reference  
1 Visit 2.30(1.82,2.90)  2.19(1.63,2.94)  
2-3 Visits  1.77(1.55,2.03)  5.99(4.82,7.47)  
4-9 Visits 9.69(8.30,11.32)  8.16(7.03,9.47)  
10-12 Visits 10.57(8.69,12.86)  8.31(7.06,9.79)  
>13 Visits 14.90(10.91,20.37)  10.72(8.55,13.45)  
Usual Source of Care   <.0001  .07 
       No Reference  Reference  
       Yes 4.60(3.50,6.05)  1.64(1.09,2.48)  
Health condition  <.0001  .06 
      Good/Excellent 2.90(2.40,3.50)  2.42(1.88,3.11)  
       Average 1.60(1.37,1.85)  1.38(1.11,1.71)  
     Poor/Fair Reference  Reference  
Insurance  <.0001  .34 
       No Reference  Reference  
     Yes 1.92(1.59,2.33)  2.76(2.30,3.81)  
Education   .06  
 
      College Graduate 1.11(0.97,1.26)  
 
 
     High School Graduate 1.03(0.87,1.14)  
 
 
    Less than High School  Reference  
 
 
Ethnicity  .05  .41 
Black 0.84(0.67,1.06)  0.78(0.60,1.00)  
Hispanic  0.79(0.61,1.02)  0.89(0.64,1.25)  
Other  0.68(0.47,0.97)  0.75(0.55,1.03)  
White Reference  Reference  
Income  .82  
 
Above Poverty Line 1.02(0.84,1.25)  
 
 
Below Poverty Line Reference  
 
 
Insurance Type  <.0001  .69 
Medicaid/Medigap  1.52(1.14,2.02)  0.85(0.63,1.16)  
Medicare 1.37(1.17,1.60)  0.99(0.82,1.21)  
None 0.65(0.53,0.79)  0.39(0.32,0.48)  
Other 1.44(1.25,1.65)  1.02(0.93,1.14)  
Private Reference  Reference  
A Marginal Model with Generalized Estimating Equations was used to account for clustering within year; 
probability modeled was whether diabetic subjects had a proper diabetes diagnosis 
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ǂWald 𝜒2 test, at α=0.05 
Missing Data: Insurance(n=4), Insurance Type(n=10), Education (n=6), Utilization (n=4), Usual Source of 
Care (n=0), Health Condition (n=2), Sex (n=0), Ethnicity (n=0), Income (n=367) 
Definitions: ACA- Affordable Care Act, CI- Confidence Interval, OR- Odds Ratio, DM- Diabetes Mellitus  
